Syntara (ASX:SNT) – Webinar Presentation


Gary Phillips – CEO – Syntara (ASX:SNT) is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. The company has ongoing trials in myelofibrosis, myelodysplastic syndrome, scar prevention, modifcation of existing scars, isolated REM sleep behaviours disorder and Parkinson's Disease.

About Finance News Network

Established in 2006, the Finance News Network is one of Australia's largest providers of online business and finance news. Our news is distributed across some of Australia’s most prominent investment platforms. The network connects investors with investment opportunities, the latest ASX news, CEO and fund manager interviews and investor webinars. Keep your finger on the pulse and stay abreast of markets. Tune in to FNN. FNN is a subsidary of Sequoia Financial Group

View more articles by Finance News Network →